3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
2
Lymphoid
2
Classical hematology
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Leukemia, Myeloid, Acute
1
Febrile Neutropenia
1
Disease
1
Interventions
Cyclophosphamide
58
fludarabine phosphate
53
Mycophenolic Acid
36
Whole-Body Irradiation
35
Peripheral Blood Stem Cell Transplantation
35
Busulfan
33
Cyclosporine
32
Antilymphocyte Serum
27
Tacrolimus
26
Melphalan
25
Filgrastim
22
Cord Blood Stem Cell Transplantation
21
fludarabine
20
Radiotherapy
20
Methotrexate
16
Methylprednisolone
15
Thiotepa
12
Etoposide
11
Cytarabine
11
Granulocyte Colony-Stimulating Factor
7
Cyclosporins
7
Rituximab
6
thymoglobulin
5
Sirolimus
5
Leucovorin
4
Bortezomib
4
Bone Marrow Transplantation
4
sargramostim
3
merphos
3
Vorinostat
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Precursor Cell Lymphoblastic Leukemia-Lymphoma
×
Positron Emission Tomography Computed Tomography
×
Classical hematology
×
Clear all
NCT03429387
2022-05-17
PIPPIN
Peter MacCallum Cancer Centre, Australia
Phase NA
Completed
147 enrolled